Find out more ways to treat psoriasis in the future

Published Date: 02 Mar 2023

According to MBA MD Andrew Blauvelt, the development of oral biologics and early treatment to replace the disease is a possibility.

Read Full News

Latest News

US DOJ Closes Criminal Probe Into Abbott Over Baby Formula Plant, WSJ Reports

The U.S. Justice Department closed a criminal probe into Abbott Laboratories over its handling of a baby formula ⁠plant linked to potentially deadly bacteria and infant...

FDA Approves Risankizumab for Children With Psoriasis, PsA

The interleukin 23 inhibitor was approved for treating moderate-to-severe plaque psoriasis in adults in 2019 and for active psoriatic arthritis in adults in 2022.

Tattooed Skin: A Novel SSI Risk Factor in Spine Surgery

Tattooed skin at the operative site nearly triples the risk for surgical site infections in spine surgery, demanding individualised perioperative protocols.

Can Bimekizumab Match IL-23 Inhibitors in Psoriasis?

A retrospective study finds that bimekizumab yields comparable drug survival to interleukin-23 inhibitors after the failure of interleukin-17 inhibitors in patients with psoriasis.

Traveling in Europe: Should Mosquito Risks Be on Your Radar?

Travel medicine specialists say that mosquito protection deserves the same attention as sunscreen because vector-borne infections become more common in Europe.

To Heal Stubborn Wounds, Scientists Look to Nanomaterials

Slow-healing lesions — common in diabetics and burn victims — can lead to lingering infections that resist antibiotic treatment. A new approach using light-activated therapies may offer a solution.

Todays Updates

Vistagen's Anxiety Disorder Drug Misses Main Goal in Late-stage Trial, Shares Plummet

Vistagen Therapeutics said on Tuesday its experimental anxiety disorder drug failed to meet the main goal of a late-stage ⁠trial testing its ability to reduce symptoms in...

Combined Models With AI Improve Breast Cancer Prediction

Combining mammography AI, polygenic, and clinical risk models improves 10-year breast cancer risk prediction compared with any single model.

Todays Updates

Vistagen's Anxiety Disorder Drug Misses Main Goal in Late-stage Trial, Shares Plummet

Vistagen Therapeutics said on Tuesday its experimental anxiety disorder drug failed to meet the main goal of a late-stage ⁠trial testing its ability to reduce symptoms in...

Combined Models With AI Improve Breast Cancer Prediction

Combining mammography AI, polygenic, and clinical risk models improves 10-year breast cancer risk prediction compared with any single model.

Latest News

The U.S. Justice Department closed a criminal probe into Abbott Laboratories over its handling of a baby formula ⁠plant linked to potentially deadly bacteria and infant...

The interleukin 23 inhibitor was approved for treating moderate-to-severe plaque psoriasis in adults in 2019 and for active psoriatic arthritis in adults in 2022.

Tattooed skin at the operative site nearly triples the risk for surgical site infections in spine surgery, demanding individualised perioperative protocols.

A retrospective study finds that bimekizumab yields comparable drug survival to interleukin-23 inhibitors after the failure of interleukin-17 inhibitors in patients with psoriasis.

Travel medicine specialists say that mosquito protection deserves the same attention as sunscreen because vector-borne infections become more common in Europe.

Slow-healing lesions — common in diabetics and burn victims — can lead to lingering infections that resist antibiotic treatment. A new approach using light-activated therapies may offer a solution.

News All Time

Are Drug‑Resistant Infections Outpacing Industry Efforts?

High-quality research and proper antimicrobial stewardship can hold the key to mitigating antibiotic resistance.

Vulvar Melanoma Outcomes Worse With Surgery Delay

Surgical delays of 91 days and longer from diagnostic biopsy are linked to positive margins and worse survival in patients with early-stage vulvar melanoma, study finds.

Elicio Shares Slide After Pancreatic Cancer Vaccine Falls Short in Mid-stage Study

Elicio Therapeutics shares fell about 72% on Monday after the biotech firm's experimental pancreatic cancer vaccine ⁠failed to significantly extend the time patients lived...

Social Media Sunscreen Recipes Raise Safety Concerns

Homemade sunscreen recipes are gaining attention, but laboratory studies suggest they may reduce ultraviolet damage unevenly and fail against key sunburn markers.

Cutaneous Lupus Flares Peak During Late Perimenopause

Cutaneous lupus flares increase during late perimenopause and remain elevated after menopause, study finds.

Somatic Cancer Symptoms May Be Overattributed to Depression

Experts offer advice for treating symptoms of ovarian, breast, and other cancers that are not driven by depression and explain why it’s essential to discern the difference.

UKHSA: New Pandemic More Than 25% Likely Within 5 Years

Influenza and novel coronavirus top a new UKHSA threat register covering 22 risks, from dengue to drug-resistant infections.

Most OTC Vaginal Moisturizers Contain Contact Allergens

Over-the-counter vaginal and vulvar moisturizers often contain allergens, with inaccurate marketing claims, a study shows.

Secondary Syphilis Sign Shows Reliable Histologic Pattern

Condyloma lata in secondary syphilis shows consistent histopathologic findings that may help prevent misdiagnosis.

Drop Flare Fears to Fix Rheumatic Vaccination Gaps

Vaccination remains the best measure to protect immunosuppressed patients, but new evidence suggests a rethink of scheduling.

Takeda's AI-crafted Psoriasis Pill Tops Bristol Myers' Sotyktu in Head-to-head Trial

Japan's Takeda Pharmaceutical said on Thursday its experimental once-daily psoriasis pill, developed with the help of AI, outperformed Bristol ⁠Myers Squibb's approved drug...

Can Age-Old Chinese Therapy Reduce Insulin Needs in T2D?

Acupuncture may reduce insulin requirements to a greater extent than a sham treatment in adults with type 2 diabetes and overweight receiving insulin therapy, a trial suggests.

Golimumab Shows Benefit in Refractory HS

More than half of patients with treatment-refractory hidradenitis suppurativa achieve meaningful disease improvement with golimumab therapy in a study.

Psoriasis in Pregnancy: Study Supports Safety of Biologics

In pregnant women with psoriasis, biologic therapy is not linked to increased risk for adverse maternal or neonatal outcomes compared with unexposed patients, study finds.

How Can Canada Improve Access to Dermatologic Care?

The Canadian Dermatology Association proposes increasing residency spots, expanding technology, and integrating international graduates into the workforce.

Choosing a Journal: What Matters More Than Impact Factor?

Researchers weigh peer review, indexing, transparency, and audience reach alongside impact factor when deciding where to submit scientific work.

Recommended News For You

Photoacoustic spectral analysis for gaining knowledge of the tumor microenvironment.

La FDA ha approvato Talzenna per trattare il cancro alla prostata metastatico che non è resistente alla castrazione.

For MDS-Related Anemia, Telomerase Inhibitor Approved.

FDA Authorizes Three Different Uses for Injectable Antibiotic.

The standard for high-risk prostate cancer is supported by a study using high-dose RT and long-term ADT.

Discovery reveals protein involved in Parkinson's disease also drives skin cancer

An understudied type of breast cancer poses a lurking threat

Recommended Articles For You

Machine Learning for Bone Marrow Ecosystem Analysis 

Decoding Granular Cell Tumor: What You Need to Know 

Unraveling the Mysteries of Hematocrit: How It Impacts Your Health 

Beyond the Biopsy: Decoding Tumor Biology Through the Lens of Radiogenomics 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Cancer diagnosis does not spur improvements to survivors' diets or eating habits

2.

Infection Burden High With Myeloma T-Cell Therapies

3.

Capivasertib Wins Metastatic Prostate Cancer Approval

4.

Frontline Decisions in Transplant-Ineligible Multiple Myeloma: Evaluating Quadruplet Therapy

5.

Cancer Treatment Ups CV Risk; Therapy's Next Big Thing; Nude Photos Settlement

1.

Benefits of Neutrophilia: Harnessing the Power of White Blood Cells to Promote Health and Well-Being

2.

Practical Directions in Oncology in Daily Practice

3.

Neutrophil Profiling and AI Rewrites Cancer Diagnosis

4.

The Importance of Iron Rich Foods in Preventing and Treating Anemia 

5.

Emerging Insights in Hematology for Better Care

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

International Cancer Conference

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

International Lung Cancer Congress®

1.

Navigating the Complexities of Ph Negative ALL - Part XV

2.

Preventing Blood Clots: The Importance of Venous Thromboembolism Management

3.

The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma

4.

Summary of The Impact of CDK4/6 Inhibition in HR+/HER2- Metastatic Breast Cancer: Insights from PALOMA-2

5.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot